Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy.
Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy. Research Abstract Details
Four patients with biochemical prostate-specific antigen (PSA) failure with suspected local recurrence at the vesico-urethral anastomotic site after radical prostatectomy were treated using a high-intensity focused ultrasound (HIFU) device (Sonablate 500) under caudal or spinal anesthesia. The pretreatment PSA levels ranged from 0.318 to 0.898 ng/mL and their Gleason scores ranged between 5 and 7. HIFU treatment was carried out six times in four patients. The median time of operation and follow-up period were 30 min (range, 15-37) and 13 months (range, 7-18), respectively. In all patients, the median PSA levels decreased from 0.555 ng/mL (range, 0.318-0.898) to 0.137 ng/mL (range, 0.102-0.290). The median PSA nadir after each HIFU was 0.054 ng/mL (range, 0.008-0.097). No major complications were noted. HIFU may be useful for the therapy of vesicourethral anastomostic lesion in patients with PSA failure after prostatectomy.
Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy. Publishing Authors By Initials
Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: International journal of urology : official journa
VOLUME: 14
Page Numbers: 1048-50
Journal Abbreviation: Int. J. Urol.
ISSN: 0919-8172
DAY: 24
MONTH: Nov
YEAR: 2007
Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 9440237
Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy.
AFFILIATION: Takanobashi Central Hospital, 2-4-16 Kokutaiji-cho Naka-ku, Hiroshima, Japan. m6-hayashi@hi.enjoy.ne.jp
Country: Australia
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Int J Urol
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy Related Publications